Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a page refresh. This appears to be a metadata-level update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:13:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays an updated revision label from v3.6.0 to v3.6.2, indicating a newer build of the page without changes to visible content or features.
    Difference
    0.1%
    Check dated 2026-06-27T07:46:29.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows recruitment status as 'No longer looking for participants', indicating enrollment for this study has ended. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Interventions/Treatment header was updated; a revision note (Revision: v3.6.0) is also included.
    Difference
    0.4%
    Check dated 2026-06-13T05:09:05.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page footer now includes Moffitt branding and related trial links. The revision label changed from v3.5.4 to v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-05T23:55:54.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page’s footer now omits the H. Lee Moffitt Cancer Center branding and the sponsor-provided links to drug information, study documents, and helpful resources. This changes how the page references its affiliated institution and directs users to related materials.
    Difference
    0.3%
    Check dated 2026-05-29T23:00:27.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor site/template update.
    Difference
    0.1%
    Check dated 2026-05-15T15:29:47.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.